NASDAQ
18.62USD
+0.62 (+3.44%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.1B
P/E
—
EPS
—
Beta
0.87
52W range
16.665-51.18
Day range
17.71–18.66
Open
17.80
Prev close
18.00
Volume
1.2M
Avg volume
1.6M
Dividend
0.00
IPO
2021-09-15
https://www.prnewswire.com/news-releases/prct-investors-have-opportunity-to-lead-procept-biorobotics-corporation-securities-fraud-lawsuit-302835753.html · 7/28/2026-1.00
https://www.prnewswire.com/news-releases/prct-investor-alert-robbins-geller-rudman--dowd-llp-files-class-action-lawsuit-against-procept-biorobotics-corporation-and-announces-opportunity-for-investors-with-substantial-losses-to-lead-the-procept-class-action-lawsuit-302834531.html · 7/27/2026-1.00
https://www.businesswire.com/news/home/20260726219673/en/PRCT-Investors-Have-Opportunity-to-Lead-PROCEPT-BioRobotics-Corporation-Securities-Fraud-Lawsuit-with-the-Schall-Law-Firm/ · 7/26/2026-1.00
https://www.businesswire.com/news/home/20260724015372/en/PROCEPT-BioRobotics-Corporation-NASDAQ-PRCT-Investors-Who-Suffered-Losses-May-Be-Eligible-to-Participate-in-Securities-Class-Action-Contact-Robbins-LLP-for-Information-About-Recovering-Your-Losses/ · 7/25/2026-1.00
https://www.benzinga.com/analyst-stock-ratings/initiation/26/06/60065637/this-take-two-interactive-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday · 6/24/2026+1.00
https://seekingalpha.com/article/4903515-procept-biorobotics-corporation-prct-presents-at-bank-of-america-global-healthcare-conference · 5/13/2026+0.00
https://www.businesswire.com/news/home/20260422877260/en/Securities-Fraud-Investigation-Into-PROCEPT-BioRobotics-Corporation-PRCT-Continues-%E2%80%93-Shareholders-Who-Lost-Money-Urged-To-Contact-The-Law-Offices-of-Frank-R.-Cruz/ · 4/22/2026-0.80
https://www.zacks.com/stock/news/2896136/inogen-ingn-surges-6-9-is-this-an-indication-of-further-gains · 4/8/2026-0.70
https://www.defenseworld.net/2026/03/15/arrowmark-colorado-holdings-llc-raises-stake-in-procept-biorobotics-corporation-prct.html · 3/15/2026+0.50
https://www.businesswire.com/news/home/20260309108760/en/Securities-Fraud-Investigation-Into-PROCEPT-BioRobotics-Corporation-PRCT-Announced-%E2%80%93-Shareholders-Who-Lost-Money-Urged-To-Contact-The-Law-Offices-of-Frank-R.-Cruz/ · 3/10/2026-0.80
https://www.defenseworld.net/2026/03/08/procept-biorobotics-nasdaqprct-trading-down-6-9-time-to-sell.html · 3/8/2026-0.60
https://www.newsfilecorp.com/release/286152/Lost-Money-on-PROCEPT-BioRobotics-Corporation-PRCT-Contact-Levi-Korsinsky-About-Fraud-Investigation · 3/3/2026-1.00
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
